Citation Impact
Citing Papers
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
2000 Standout
Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial
2001
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Molecular biology of squamous cell carcinoma of the head and neck
2006
Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens
2001
Head and neck cancer
2008 Standout
Paclitaxel (Taxol)
1995 Standout
Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States)
2003
Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma
2000
Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens
2001
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Second-Line Chemotherapy with 96-Hour Infusional Paclitaxel in Refractory Non-Small Cell Lung Cancer: Report of a Phase II Trial
1999
Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: Continuing research and implications for clinical practice
2007
Atherosclerosis — An Inflammatory Disease
1999 Standout
Interventions for treating oral leukoplakia
2006
A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)
2000
A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer
2000
Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
2001
Evolving 'omics' technologies for diagnostics of head and neck cancer
2008
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Long-Term Impact of Smoking on Lung Epithelial Proliferation in Current and Former Smokers
2001
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
1996 Standout
Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma
2001
Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer
1999
Membrane assembly in vitro : Synthesis, glycosylatio, and asymmetric insertion of a transmembrane protein
1977 StandoutNobel
Receptor-mediated transcellular transport of immunoglobulin: synthesis of secretory component as multiple and larger transmembrane forms.
1980 StandoutNobel
Reconstitution and functional comparison of purified GlpF and AqpZ, the glycerol and water channels from Escherichia coli
2001 StandoutNobel
Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies.
1993 StandoutNobel
An activity in rat tissues that modifies nitrotyrosine-containing proteins
1998 StandoutNobel
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
1993 StandoutNobel
Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney.
1996 StandoutNobel
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Regional mapping of prion proteins in brain.
1992 StandoutNobel
An octamer of histones in chromatin and free in solution.
1975 StandoutNobel
Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9
2002 StandoutNobel
Phorbol esters promote alpha 1-adrenergic receptor phosphorylation and receptor uncoupling from inositol phospholipid metabolism.
1985 StandoutNobel
Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype.
1988 StandoutNobel
Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family.
1991 StandoutNobel
Myristoylated alpha subunits of guanine nucleotide-binding regulatory proteins.
1987 StandoutNobel
Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment
2008
Escherichia coli mutS-encoded protein binds to mismatched DNA base pairs.
1986 StandoutNobel
A family of RIM-binding proteins regulated by alternative splicing: Implications for the genesis of synaptic active zones
2002 StandoutNobel
Organization and expression of early genes of simian virus 40
1978 StandoutNobel
A lamin B receptor in the nuclear envelope.
1988 StandoutNobel
Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer.
1994 StandoutNobel
Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis.
1980 StandoutNobel
Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
1997
Fenretinide Activity in Retinoid-Resistant Oral Leukoplakia
2006
Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2006
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
2000
Purification of the regulatory component of adenylate cyclase.
1980 StandoutNobel
Gemcitabine as Second-Line Treatment for Advanced Non–Small-Cell Lung Cancer: A Phase II Trial
1999
Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity.
1997
Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes.
1990 StandoutNobel
Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells.
1991 StandoutNobel
Aquaglyceroporin AQP9: Solute permeation and metabolic control of expression in liver
2003 StandoutNobel
Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor.
1986 StandoutNobel
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study
2001
Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation.
1992 StandoutNobel
Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.
1994 StandoutNobel
A cellular protein that associates with the transforming protein of Rous sarcoma virus is also a heat-shock protein.
1981 StandoutNobel
Smoking and Smokeless Tobacco-Associated Human Buccal Cell Mutations and Their Association with Oral Cancer—A Review
2006
ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation.
1980 StandoutNobel
Detection of prokaryotic signal peptidase in an Escherichia coli membrane fraction: endoproteolytic cleavage of nascent f1 pre-coat protein.
1978 StandoutNobel
cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family.
1989 StandoutNobel
Second-line chemotherapy for non-small cell lung cancer
2002
Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain.
1988 StandoutNobel
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Purified prion proteins and scrapie infectivity copartition into liposomes.
1987 StandoutNobel
Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses
1999 StandoutNobel
Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase.
1991 StandoutNobel
Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes.
1984 StandoutNobel
G protein gamma subunits contain a 20-carbon isoprenoid.
1990 StandoutNobel
Competing Causes of Death and Second Primary Tumors in Patients with Locoregionally Advanced Head and Neck Cancer Treated with Chemoradiotherapy
2004
Aquaporin-6: An intracellular vesicle water channel protein in renal epithelia
1999 StandoutNobel
Works of Steven E. Benner being referenced
Chemoprevention strategies for the control of cancer
1993
Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients
2006
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer
2001
Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.
1994
Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.
1994
Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.
1995
A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck
2001
Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
1995
Multicenter Phase III Study of Uracil/Tegafur and Oral Leucovorin Versus Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer
2002
Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia.
1994
Prevention of Second Primary Tumors With Isotretinoin in Patients With Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up
1994
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
2001
Predicting cancer development in oral leukoplakia: ten years of translational research.
2000
Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis
1994